ALSTON & BIRD LLP for FRESENIUS MEDICAL CARE
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| Year-End Amendment | Feb 14, 2008 | $80,000 | Replaced |
| Year-End Amendment (this page) | May 1, 2008 | $80,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 3162, The Childrens Health and Medicare Protection Act, Title VIC and Section 703. Proposed changes to end-stage renal disease payment policies and regulations in the CY08 Physician Fee Schedule Proposed Rule. Phase III of the Stark Regulation governing physician self-referrals, published in the Federal Register on September 5, 2007. U.S. Food and Drug Administration (FDA) oversight of use and risks of erythropoiesis-stimulating agents for the treatment of anemia in patients with chronic kidney failure.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL | N/A |
| ERIN L DARLING | — |
| DAVID HEBERT | — |
| MARK RAYDER | N/A |
| THOMAS A SCULLY | N/A |
| TIMOTHY P TRYSLA | N/A |
| MARILYN K YAGER | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.